SEC Form 4 · accession 0001179110-19-000198
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C. David Nicholson
Officer — EVP Chief R&D Officer
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 3:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Dec 31, 2018 | F | 1,150 | $133.66 | D | 16,207 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Remarks
Exhibit 24 - Power of Attorney